Please assess the completion status of the following clinical trial:

Trial Title: Assisted Animal Therapy: ReAnimal

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients hospitalized in surgical ICU, not in acute stage of their ICU stay~* adult patient~* able to receive information and to give consent,~* with national social insurance~Exclusion Criteria:~* afraid of animal, dog phobia~* allergic to dog~* immunodepression (neutrophils \<0.5 G/L), induced by treatment (chemotherapy, immunosuppressing treatment with high doses, corticotherapy for more than 2 weeks) or induced by disease (malignant blood disease, AIDS, transplantation, or splenectomy)~* sepsis ongoing~* patient known for having multidrug resistant bacteria~* wounds, or large bandages that could not correctly be covered, including external fixer~* central venous catheter, arterial catheter~* tracheostomy~* agitation, aggressiveness~* pregnant women~* patient deprived of freedom by juridical or administrative decision~* patient under legal protection measure~* patient receiving enforced psychiatric treatment~* patient admitted in a sanitary or social department.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Animal assisted therapy group (Type: EXPERIMENTAL): Patients included in this arm will have animal assisted therapy session in a specific room outside of the ICU. They will also have blood sampling for multidrug resistant bacteria screening and will answer to questionnaires
- Control Group (Type: ACTIVE_COMPARATOR): Patients included in this arm will have a sham session : they will leave their hospital bedroom, to go in the AAT session room. There, no specific activity is planned. After 20 minutes, the patient will go back to his room. They will also have blood sampling for multidrug resistant bacteria screening and will answer to questionnaires

Based on this trial design, predict the completion outcome and termination type (if applicable).